Noriko Okada Selected Research

Noriko Okada Research Topics

Disease

12	Inflammation (Inflammations) 12/2013 - 01/2002
7	Infections 03/2011 - 03/2002
6	Neoplasms (Cancer) 12/2010 - 02/2002
5	Shock 12/2012 - 01/2002
3	Peritonitis 12/2013 - 06/2011
3	Wounds and Injuries (Trauma) 12/2013 - 06/2011
3	HIV Infections (HIV Infection) 02/2007 - 07/2003
2	Neonatal Sepsis 12/2012 - 12/2010
2	Virus Diseases (Viral Diseases) 03/2011 - 11/2004
2	Hepatitis 01/2010 - 01/2005
2	Anemia 01/2008 - 01/2003
2	Acquired Immunodeficiency Syndrome (AIDS) 07/2003 - 03/2002
1	Mesenteric Ischemia 03/2016
1	Reperfusion Injury 01/2016
1	Chronic Kidney Failure (Chronic Renal Failure) 12/2013
1	Cardiac Tamponade 11/2013
1	Hereditary Angioedemas 12/2012
1	Sepsis (Septicemia) 12/2012
1	Peritoneal Fibrosis 05/2012
1	Human Influenza (Influenza) 03/2011
1	Autoimmune Diseases (Autoimmune Disease) 12/2010
1	Lymphoma (Lymphomas) 12/2010
1	Pulmonary Hypertension 12/2010
1	Hypotension (Low Blood Pressure) 12/2010
1	Renal Insufficiency (Renal Failure) 01/2008
1	Gastritis 09/2005
1	Asthma (Bronchial Asthma) 01/2005
1	Anaphylaxis (Anaphylactic Shock) 01/2005
1	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 11/2004
1	Adenocarcinoma 07/2004
1	Fibrosarcoma 07/2004
1	Colorectal Neoplasms (Colorectal Cancer) 06/2004
1	Neoplasm Metastasis (Metastasis) 06/2004
1	Stomach Neoplasms (Stomach Cancer) 01/2004

Drug/Important Bio-Agent (IBA)

16	Complement System Proteins (Complement)IBA 12/2013 - 01/2002
8	Peptides (Polypeptides)IBA 01/2016 - 06/2003
8	Monoclonal AntibodiesIBA 01/2007 - 01/2002
5	Proteins (Proteins, Gene)FDA Link 09/2005 - 01/2003
4	Complement C5a (Complement 5a)IBA 03/2016 - 06/2003
3	AnaphylatoxinsIBA 01/2016 - 01/2005
3	CytokinesIBA 07/2011 - 01/2010
3	CD55 Antigens (Decay Accelerating Factor)IBA 09/2005 - 01/2003
3	Immunoglobulin M (IgM)IBA 01/2005 - 02/2002
3	LipopolysaccharidesIBA 10/2004 - 01/2002
2	Endothelin Receptor AntagonistsIBA 12/2012 - 12/2010
2	HMGB1 Protein (HMG1)IBA 07/2011 - 12/2010
2	Anaphylatoxin C5a ReceptorIBA 07/2011 - 01/2005
2	Erythropoietin FDA Link 01/2008 - 01/2003
2	Complement Receptors (Complement Receptor)IBA 07/2004 - 01/2002
2	AntigensIBA 06/2004 - 07/2003
1	Dialysis SolutionsIBA 12/2013
1	peptide AIBA 11/2013
1	AntioxidantsIBA 12/2012
1	Oxidants (Oxidizing Agents)IBA 12/2012
1	Interleukin-6 (Interleukin 6)IBA 12/2012
1	FibrinIBA 05/2012
1	ZymosanIBA 05/2012
1	LigandsIBA 07/2011
1	Therapeutic UsesIBA 07/2011
1	Glucose (Dextrose)FDA LinkGeneric 06/2011
1	CoagulantsIBA 12/2010
1	GasesIBA 12/2010
1	Rituximab (Mabthera)FDA Link 12/2010
1	ChemokinesIBA 01/2010
1	Concanavalin AIBA 01/2010
1	Enfuvirtide (Fuzeon)FDA Link 02/2007
1	Chemokine ReceptorsIBA 02/2007
1	Peptide FragmentsIBA 02/2007
1	CCR5 Receptors (CCR5 Receptor)IBA 02/2007
1	Viral Envelope ProteinsIBA 02/2007
1	Amino Acids FDA Link 02/2007
1	Indicators and Reagents (Reagents)IBA 02/2007
1	beta-GlucansIBA 01/2007
1	Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA 09/2005
1	UreaseIBA 09/2005
1	Urea (Carbamide)FDA LinkGeneric 09/2005
1	Membrane Cofactor ProteinIBA 09/2005
1	CD59 AntigensIBA 09/2005
1	LeukotrienesIBA 01/2005
1	acetylated peptide AIBA 01/2005
1	Messenger RNA (mRNA)IBA 11/2004
1	Staphylococcal Protein A (Protein A)IBA 11/2004
1	CCR4 ReceptorsIBA 11/2004
1	Complementary DNA (cDNA)IBA 11/2004
1	Bispecific AntibodiesIBA 06/2004
1	cobra venom factorIBA 06/2004
1	Antiviral Agents (Antivirals)IBA 02/2004
1	interferon tauIBA 02/2004
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 01/2004
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2003
1	Protein Kinase CIBA 10/2003

Therapy/Procedure

9	Therapeutics 12/2013 - 03/2002
4	Immunotherapy 11/2004 - 02/2002
2	Peritoneal Dialysis 12/2013 - 05/2012
2	Ligation 12/2012 - 12/2010
2	Cardiopulmonary Resuscitation (CPR) 01/2010 - 01/2002
2	Renal Dialysis (Hemodialysis) 01/2008 - 01/2003
1	Catheters 12/2013
1	Physical Therapy Modalities (Physical Therapy Technique) 12/2013
1	Intravenous Administration 01/2007